Checkpoint checkmate: Microbiota modulation of cancer immunotherapy

Eric C. Keen; Terence S. Crofts; Gautam Dantas

doi:10.1373/clinchem.2017.286229

Checkpoint checkmate: Microbiota modulation of cancer immunotherapy

Eric C. Keen, Terence S. Crofts, Gautam Dantas

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	1280-1283
Number of pages	4
Journal	Clinical chemistry
Volume	64
Issue number	9
DOIs	https://doi.org/10.1373/clinchem.2017.286229
State	Published - Sep 2018

Access to Document

10.1373/clinchem.2017.286229

Cite this

@article{96d082ae8efb4a149a86aafc82284c31,

title = "Checkpoint checkmate: Microbiota modulation of cancer immunotherapy",

author = "Keen, {Eric C.} and Crofts, {Terence S.} and Gautam Dantas",

note = "Funding Information: Employment or Leadership: None declared. Consultant or Advisory Role: None declared. Stock Ownership: None declared. Honoraria: None declared. Research Funding: E.C. Keen, National Science Foundation Graduate Research Fellowship (DGE-1143945); T.S. Crofts, National Institute of Child Health and Development training grant through award number T32 HD049305 (Kelle H. Moley, Principal Investigator) and a National Institute of Diabetes and Digestive and Kidney Diseases training grant through award number T32 DK077653 (Phillip I. Tarr, Principal Investigator); G. Dantas, awards through the Edward Mallinckrodt Jr. Foundation (Scholar Award), the National Institute of Allergy and Infectious Diseases (NIAID: https://www.niaid.nih.gov/), and the Eunice Kennedy Shriver National Institute of Child Health & Human Development (https://www.nichd.nih.gov/) of the National Institutes of Health (NIH) under award numbers R01AI123394 and R01HD092414, respectively. Expert Testimony: None declared. Patents: None declared.",

year = "2018",

month = sep,

doi = "10.1373/clinchem.2017.286229",

language = "English",

volume = "64",

pages = "1280--1283",

journal = "Clinical chemistry",

issn = "0009-9147",

number = "9",

}

TY - JOUR

T1 - Checkpoint checkmate

T2 - Microbiota modulation of cancer immunotherapy

AU - Keen, Eric C.

AU - Crofts, Terence S.

AU - Dantas, Gautam

N1 - Funding Information: Employment or Leadership: None declared. Consultant or Advisory Role: None declared. Stock Ownership: None declared. Honoraria: None declared. Research Funding: E.C. Keen, National Science Foundation Graduate Research Fellowship (DGE-1143945); T.S. Crofts, National Institute of Child Health and Development training grant through award number T32 HD049305 (Kelle H. Moley, Principal Investigator) and a National Institute of Diabetes and Digestive and Kidney Diseases training grant through award number T32 DK077653 (Phillip I. Tarr, Principal Investigator); G. Dantas, awards through the Edward Mallinckrodt Jr. Foundation (Scholar Award), the National Institute of Allergy and Infectious Diseases (NIAID: https://www.niaid.nih.gov/), and the Eunice Kennedy Shriver National Institute of Child Health & Human Development (https://www.nichd.nih.gov/) of the National Institutes of Health (NIH) under award numbers R01AI123394 and R01HD092414, respectively. Expert Testimony: None declared. Patents: None declared.

PY - 2018/9

Y1 - 2018/9

UR - http://www.scopus.com/inward/record.url?scp=85052452862&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2017.286229

DO - 10.1373/clinchem.2017.286229

M3 - Review article

C2 - 29691222

AN - SCOPUS:85052452862

SN - 0009-9147

VL - 64

SP - 1280

EP - 1283

JO - Clinical chemistry

JF - Clinical chemistry

IS - 9

ER -

Checkpoint checkmate: Microbiota modulation of cancer immunotherapy

Access to Document

Other files and links

Cite this